JLE

Epileptic Disorders

MENU

Drug-resistant epilepsy after treatment for childhood acute lymphocytic leukaemia: from focal epilepsy to Lennox-Gastaut syndrome Volume 18, issue 4, December 2016

  • [Baumann et al., 2007] Baumann C.R., Acciarri N., Bertalanffy H. Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia. 2007;48:559-563.
  • [Bhojwani et al., 2014] Bhojwani D., Sabin N.D., Pei D. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol. 2014;32:949-959.
  • [Blume, 2001] Blume W.T. Pathogenesis of Lennox-Gastaut syndrome: considerations and hypotheses. Epileptic Disord. 2001;3:183-196.
  • [Faraci et al., 2011] Faraci M., Morana G., Bagnasco F. Magnetic resonance imaging in childhood leukemia survivors treated with cranial radiotherapy: a cross sectional, single center study. Pediatr Blood Cancer. 2011;57:240-246.
  • [Fasano and Bergen, 2009] Fasano R.E., Bergen D.C. Intractable epilepsy in patients treated for childhood acute lymphocytic leukemia. Seizure. 2009;18:298-302.
  • [Goyal et al., 2003] Goyal M., Bangert B.A., Wiznitzer M. Mesial temporal sclerosis in acute childhood leukemias. Epilepsia. 2003;44:131-134.
  • [Howlader et al., 2016] Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. 2016. http://seer.cancer.gov/csr/1975_2013/.
  • [Keezer and Del Maestro, 2009] Keezer M.R., Del Maestro R. Radiation-induced cavernous hemangiomas: case report and literature review. Can J Neurol Sci. 2009;36:303-310.
  • [Khan et al., 2003] Khan R.B., Marshman K.C., Mulhern R.K. Atonic seizures in survivors of childhood cancer. J Child Neurol. 2003;18:397-400.
  • [Maytal et al., 1995] Maytal J., Grossman R., Yusuf F.H. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia. Epilepsia. 1995;36:831-836.
  • [Mitsufuji et al., 1996] Mitsufuji N., Ikuta H., Yoshioka H., Sawada T. Lennox-Gastaut syndrome associated with leukoencephalopathy. Pediatr Neurol. 1996;15:63-65.
  • [Ochs et al., 1984] Ochs J.J., Bowman W.P., Pui C.H., Abromowitch M., Mason C., Simone J.V. Seizures in childhood lymphoblastic leukaemia patients. Lancet. 1984;2:1422-1424.
  • [Rosenow et al., 2013] Rosenow F., Alonso-Vanegas M.A., Baumgartner C. Cavernoma-related epilepsy: review and recommendations for management-report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2013;54:2025-2035.
  • [Rubinstein et al., 1975] Rubinstein L.J., Herman M.M., Long T.F., Wilbur J.R. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer. 1975;35:291-305.
  • [Vezmar et al., 2003] Vezmar S., Becker A., Bode U., Jaehde U. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy. 2003;49:92-104.